Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance

Go back to Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance

Tandem Diabetes (TNDM) Tops Q1 EPS by 1c

April 28, 2016 4:47 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.68), $0.01 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $17.67 million.

GUIDANCE:

Tandem Diabetes sees FY2016 revenue of $108-115 million, versus the consensus of... More